André-Michel Ballester

André-Michel Ballester

Private Equity Investor bei
ArchiMed SAS
68 Jahre
Health Technology
Consumer Services
Process Industries

Profil

Mr. André-Michel Ballester is a Managing Partner at ArchiMed SAS and a Managing Partner at North American Science Associates LLC.
Mr. Ballester was previously employed as a Lead Independent Director by DiaSorin SpA, a Chief Executive Officer & Director by LivaNova Plc, an Independent Director by Pixium Vision SA, an Independent Director by Mauna Kea Technologies SA, an Independent Director by Carmat SA, a Chief Executive Officer & Director by Sorin SpA, a Vice President-Europe, Middle East & Africa Region by Edwards Lifesciences Corp., a President-CardioVascular Group by Baxter Cardiovascular Group, a Chairman by Bomi Italia SpA, and a Chairman by Suan Farma SA. He also served on the board at IMI Intelligent Medical Implants AG and Natus Medical, Inc. He received his undergraduate degree from École centrale de Lille and an MBA from INSEAD.

Aktive Positionen von André-Michel Ballester

UnternehmenPositionBeginn
Private Equity Investor 01.01.2018
Corporate Officer/Principal 24.02.2025

Ehemalige bekannte Positionen von André-Michel Ballester

UnternehmenPositionEnde
LIVANOVA PLC Vorstandsvorsitzender 31.12.2016
MAUNA KEA TECHNOLOGIES Direktor/Vorstandsmitglied 17.12.2015
SORIN SPA Vorstandsvorsitzender 01.10.2015
EDWARDS LIFESCIENCES CORPORATION Corporate Officer/Principal -
Vorsitzender -
Sehen Sie sich die Erfahrung von André-Michel Ballester im Detail an

Ausbildung von André-Michel Ballester

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

78

Beziehungen ersten Grades

16

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen16

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Process Industries

Health Technology

Consumer Services

Distribution Services

Commercial Services

Health Technology

Transportation

Baxter Cardiovascular Group

Health Technology

Finance

Health Technology

  1. Börse
  2. Insiders
  3. André-Michel Ballester